ES2301554T3 - Compuestos de ureas ciclicas y su procedimiento de preparacion. - Google Patents
Compuestos de ureas ciclicas y su procedimiento de preparacion. Download PDFInfo
- Publication number
- ES2301554T3 ES2301554T3 ES01945420T ES01945420T ES2301554T3 ES 2301554 T3 ES2301554 T3 ES 2301554T3 ES 01945420 T ES01945420 T ES 01945420T ES 01945420 T ES01945420 T ES 01945420T ES 2301554 T3 ES2301554 T3 ES 2301554T3
- Authority
- ES
- Spain
- Prior art keywords
- function
- carbamic acid
- group
- derivative
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/04—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Fats And Perfumes (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0007507 | 2000-06-13 | ||
| FR0007507A FR2810039B1 (fr) | 2000-06-13 | 2000-06-13 | Composes urees cycliques et leur procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2301554T3 true ES2301554T3 (es) | 2008-07-01 |
Family
ID=8851208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01945420T Expired - Lifetime ES2301554T3 (es) | 2000-06-13 | 2001-06-13 | Compuestos de ureas ciclicas y su procedimiento de preparacion. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7186828B2 (enExample) |
| EP (2) | EP1640368A3 (enExample) |
| JP (1) | JP5054877B2 (enExample) |
| KR (1) | KR20030031001A (enExample) |
| AT (1) | ATE386728T1 (enExample) |
| AU (2) | AU6764501A (enExample) |
| CA (2) | CA2412782C (enExample) |
| DE (1) | DE60132891T2 (enExample) |
| DK (1) | DK1289968T3 (enExample) |
| ES (1) | ES2301554T3 (enExample) |
| FR (1) | FR2810039B1 (enExample) |
| IL (1) | IL153408A0 (enExample) |
| WO (1) | WO2001096318A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006016168D1 (de) * | 2005-12-29 | 2010-09-23 | Immupharma France Sa | 1,3,5-triazepin-dionen zur Behandlung von Malaria |
| AU2006331355B2 (en) * | 2005-12-29 | 2011-09-29 | Immupharma France Sa | Compositions and methods for the inhibition of phospholipase A2 |
| US7777030B2 (en) | 2005-12-29 | 2010-08-17 | Centre National de la Recherge Scientifique (CNRS) | Compositions and methods for the treatment and prevention of disease |
| AU2006331357B2 (en) * | 2005-12-29 | 2012-05-17 | Immupharma France Sa | Compositions and methods for synthesizing novel heterocyclic therapeutics |
| JP2009522236A (ja) * | 2005-12-29 | 2009-06-11 | イミュファルマ・フランス・エスアー | マラリアまたはエイズの処置のためのアザ複素環化合物 |
| US8563115B2 (en) | 2008-08-12 | 2013-10-22 | Xerox Corporation | Protective coatings for solid inkjet applications |
| US8191992B2 (en) * | 2008-12-15 | 2012-06-05 | Xerox Corporation | Protective coatings for solid inkjet applications |
| EP2548869A1 (en) * | 2011-07-20 | 2013-01-23 | Cytec Technology Corp. | Process for the Synthesis of N-substituted Cyclic Alkylene Ureas |
| CN102911130B (zh) * | 2011-08-03 | 2015-05-20 | 北京师范大学 | 一种一锅法合成脲四元环化合物的方法、合成的脲四元环化合物 |
| EP3640263A1 (en) | 2013-08-21 | 2020-04-22 | UREKA Sarl | Peptide-oligourea chimeric compounds and methods of their use |
| WO2016207726A1 (en) | 2015-06-22 | 2016-12-29 | Ureka Sarl | Bioinspired catalysis using oligourea helical foldamers |
| WO2017037142A1 (en) | 2015-08-31 | 2017-03-09 | Centre National De La Recherche Scientifique (Cnrs) | Foldamer helix bundle-based molecular encapsulation |
| AU2017252015A1 (en) | 2016-04-19 | 2018-11-08 | Ureka Sarl | Peptide-oligourea foldamer compounds and methods of their use |
| US12434075B2 (en) * | 2021-05-11 | 2025-10-07 | Celestial Oncology Inc. | Coupled robotic radiation therapy system |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2847760A1 (de) * | 1978-11-03 | 1980-05-14 | Hoechst Ag | Verfahren zur herstellung von 1,3,5-triaza-2,4,6-triketo-cycloheptan- 3,5-di-essigsaeureestern |
| US4918186A (en) * | 1986-05-06 | 1990-04-17 | Mitsui Toatsu Chemicals, Inc. | Process for producing cyclic ureas |
| KR100268694B1 (ko) * | 1991-10-11 | 2000-10-16 | 미리암 디. 메코너헤이, 블레어큐. 퍼거슨 | 레트로바이러스 프로테아제 억제제로 유용한 시클릭 우레아 및 유사체 |
| US5610294A (en) * | 1991-10-11 | 1997-03-11 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| US5637780A (en) | 1993-03-30 | 1997-06-10 | The Dupont Merck Pharmaceutical Company | Method for preparing alkylating agents and their use for alkylating cyclic ureas |
| US5508400A (en) * | 1994-04-20 | 1996-04-16 | The Du Pont Merck Pharmaceutical Company | Preparation of cyclic urea compounds |
| AU5310096A (en) * | 1995-03-17 | 1996-10-08 | Du Pont Merck Pharmaceutical Company, The | Cyclic urea hiv protease inhibitors |
| US5532356A (en) * | 1995-06-06 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Method for preparing N,N'-disubstituted cyclic ureas |
| US5532357A (en) * | 1995-06-07 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas |
| WO1997008150A1 (en) | 1995-08-22 | 1997-03-06 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors |
| NZ335919A (en) | 1996-11-08 | 2000-09-29 | Du Pont Pharm Co | (4r,5s,6s,7r)-hexahydro-1-[5-(3-aminoinazole)methyl]-3-butyl-5 ,6-dihydroxy-4,7-bis[phaenylmethyl]-2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor |
-
2000
- 2000-06-13 FR FR0007507A patent/FR2810039B1/fr not_active Expired - Lifetime
-
2001
- 2001-06-13 CA CA2412782A patent/CA2412782C/en not_active Expired - Lifetime
- 2001-06-13 KR KR1020027016995A patent/KR20030031001A/ko not_active Withdrawn
- 2001-06-13 EP EP05015015A patent/EP1640368A3/fr not_active Withdrawn
- 2001-06-13 JP JP2002510461A patent/JP5054877B2/ja not_active Expired - Fee Related
- 2001-06-13 AU AU6764501A patent/AU6764501A/xx active Pending
- 2001-06-13 DK DK01945420T patent/DK1289968T3/da active
- 2001-06-13 CA CA2778314A patent/CA2778314C/en not_active Expired - Lifetime
- 2001-06-13 EP EP01945420A patent/EP1289968B1/fr not_active Expired - Lifetime
- 2001-06-13 US US10/311,178 patent/US7186828B2/en not_active Expired - Lifetime
- 2001-06-13 IL IL15340801A patent/IL153408A0/xx unknown
- 2001-06-13 AU AU2001267645A patent/AU2001267645B2/en not_active Ceased
- 2001-06-13 DE DE60132891T patent/DE60132891T2/de not_active Expired - Lifetime
- 2001-06-13 ES ES01945420T patent/ES2301554T3/es not_active Expired - Lifetime
- 2001-06-13 WO PCT/FR2001/001837 patent/WO2001096318A1/fr not_active Ceased
- 2001-06-13 AT AT01945420T patent/ATE386728T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60132891D1 (de) | 2008-04-03 |
| US20040044199A1 (en) | 2004-03-04 |
| KR20030031001A (ko) | 2003-04-18 |
| WO2001096318A1 (fr) | 2001-12-20 |
| JP2004503546A (ja) | 2004-02-05 |
| AU2001267645B2 (en) | 2006-07-27 |
| CA2412782C (en) | 2012-08-07 |
| DE60132891T2 (de) | 2009-03-19 |
| JP5054877B2 (ja) | 2012-10-24 |
| EP1289968A1 (fr) | 2003-03-12 |
| CA2778314C (en) | 2017-01-03 |
| FR2810039B1 (fr) | 2007-05-25 |
| FR2810039A1 (fr) | 2001-12-14 |
| AU6764501A (en) | 2001-12-24 |
| CA2778314A1 (en) | 2001-12-20 |
| IL153408A0 (en) | 2003-07-06 |
| WO2001096318A8 (fr) | 2003-05-01 |
| EP1640368A2 (fr) | 2006-03-29 |
| ATE386728T1 (de) | 2008-03-15 |
| CA2412782A1 (en) | 2001-12-20 |
| EP1289968B1 (fr) | 2008-02-20 |
| US7186828B2 (en) | 2007-03-06 |
| DK1289968T3 (da) | 2008-06-23 |
| EP1640368A3 (fr) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220185846A1 (en) | Methods for synthesizing beta-homoamino acids | |
| JP5054877B2 (ja) | 環式尿素化合物及びその調製方法 | |
| US11976094B2 (en) | Method for preparing peptides | |
| FI79329B (fi) | Nytt foerfarande foer framstaellning av pentapeptiden h-arg-x-asp-y-tyr-r och vid foerfarandet anvaenda mellanprodukter. | |
| EP1212350A1 (en) | A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh 2? | |
| AU2022218486B2 (en) | Process for making arylomyin ring analogs | |
| Weidner et al. | Polymer-assisted solution phase synthesis: a general method for sequestration of byproducts formed from activated acyl-transfer reactants | |
| KR102056257B1 (ko) | 베타-턴 펩티도미메틱 사이클릭 염의 용액상 합성 및 결정화 | |
| Lecoq et al. | The couple Pro/AzaPro: A means of β-turn formation control synthesis and conformation of two azapro-containing dipeptides | |
| CA2948444C (en) | Processes for the preparation of azd5363 and intermediate used therein | |
| EP2303914B1 (en) | Peptide manufacturing process | |
| JP2020529472A (ja) | ペプチド化合物の環化放出関連する出願の相互参照 | |
| HU221619B1 (hu) | Eljárás peptidek előállítására és intermedierek | |
| ES2298827T3 (es) | Procedimiento de obtencion de n-carboxianhidridos de alfa-aminoacidos protegidos con uretano. | |
| JP2025001050A (ja) | ガニレリクス又はその塩の製造法 | |
| CA3057997C (en) | Process for making arylomyin ring analogs | |
| CN100395239C (zh) | 一种合成Nα－Boc保护的脲基丙氨酸衍生物的方法 | |
| Suhs | New guanidinium compounds for the molecular recognition of carboxylates and contributions to the synthesis of bivalent NPY Y1 receptor antagonists | |
| Zlotin et al. | Synthesis of alkyl N-(α-amidomethyl) glycinates from glycine esters, aroylamides, and formaldehyde | |
| Burton et al. | Stable isotopic labelling of heterocyclic compounds | |
| WO2000035941A2 (en) | Combinatorial process for preparing polyamines |